This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05681884
Recruitment Status : Recruiting
First Posted : January 12, 2023
Last Update Posted : October 23, 2023
Genentech, Inc.
Information provided by (Responsible Party):
Greater Houston Retina Research

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 20, 2026
Estimated Study Completion Date : April 13, 2026